![[CORAL-1 trial] Interferon-free regimen for recurrent hepatitis C after liver transplant safe and effective](https://www.2minutemedicine.com/wp-content/uploads/2014/11/10229_lores-350x250.jpg)
[CORAL-1 trial] Interferon-free regimen for recurrent hepatitis C after liver transplant safe and effective
1. 33 out of 34 post-liver transplant hepatitis C virus (HCV) patients treated with the trial regimen (ombitasavir, ABT-450/r, dasabuvir, ...
Tag: ombitasavir